Carcinogenesis, Teratogenesis & Mutagenesis ›› 2025, Vol. 37 ›› Issue (4): 336-340,345.doi: 10.3969/j.issn.1004-616x.2025.04.019

Previous Articles    

The safety evaluation of Poria-Kudzu root compound tablets

ZHENG Jifan1, ZHAI Ruixue2, LIU Jianshu2, ZHANG Li1, LIU Shibo1, MA Libo1, HU Peili1, WANG Linyuan3   

  1. 1. Toxicology and Efficacy Laboratory of Food Institute, National Institutes for Food and Drug Control, Beijing 102629;
    2. Shaanxi Functional Food Engineering Center Co., Ltd., Xi'an 710054, Shaanxi;
    3. College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102401, China
  • Received:2024-03-31 Revised:2024-09-09 Published:2025-08-05

Abstract: OBJECTIVE: To conduct a toxicological safety evaluation of Poria-Kudzu root tablets,a new health product. METHODS: A variety of recommended toxicity tests were conducted: acute oral toxicity,bacterial reverse mutation (Ames test),mammalian erythrocyte micronucleus,mouse spermatogonial chromosome aberration,and 28-day oral toxicity tests. RESULTS: The median lethal dose (LD50) of the acute oral toxicity test was >15.0 g/kg,which belongs to the non-toxic class. The results of the Ames,mammalian erythrocyte micronucleus,and mouse spermatogonial chromosome aberration tests showed no mutagenic effect. The results of the 28-day oral toxicity test indicated no significant effects on the body weight,food intake,food utilization rate,hematology,blood biochemistry,urine,organ-to-body weight ratio,and histopathology of rats. CONCLUSION: Under the experimental conditions of this study,Poria-Kudzu root tablets was non-toxic,with no relevant genotoxicity. The no-observed-adverse-effect level (NOAEL),as determined in rats,was 10.0 g/kg.

Key words: Poria-Kudzu root compound tablets, toxicity, Ames test, micronucleus, aberration

CLC Number: